PDS Biotechnology Corp Common Stock, Value, Issued
PDS Biotechnology Corp (PDSB) had Common Stock, Value, Issued of $18.45 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $18.45K.
- 2026-03-31: Common Stock, Value, Issued $18.42K.
- 2025-12-31: Common Stock, Value, Issued $18.11K.
- 2025-09-30: Common Stock, Value, Issued $15.74K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $18.45K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $18.42K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $18.11K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $15.74K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $15.39K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $15.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $12.54K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $12.15K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $12.14K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $12.10K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $10.92K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $10.23K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $10.19K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $10.14K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $9.96K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $9.39K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $9.39K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $9.39K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $9.39K 10-K · filed 2023-03-28 | |
| 2021-09-30 | $9.38K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $9.38K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $7.35K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $7.35K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $7.35K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $5.06K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $5.06K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.74K 10-K · filed 2021-03-18 | |
| 2019-09-30 | $1.74K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.71K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $1.71K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.13K 10-K · filed 2020-03-27 | $10.59K 10-K · filed 2019-02-21 |
| 2018-09-30 | $10.55K 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $10.55K 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $10.52K 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $10.40K 10-K · filed 2019-02-21 | |
| 2017-09-30 | $10.40K 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $10.39K 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $9.79K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $9.76K 10-K · filed 2018-03-01 | |
| 2016-09-30 | $9.75K 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $9.73K 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $9.72K 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $9.72K 10-K · filed 2017-03-02 | |
| 2015-09-30 | $770.00 10-Q · filed 2015-11-06 | |
| 2014-12-31 | $770.00 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |